Cargando…

Anticholinergic syndrome following an unintentional overdose of scopolamine

Scopolamine hydrobromide (hyoscine) is an antimuscarinic drug which is primarily used in the prophylaxis and treatment of motion sickness and as a premedication to dry bronchial and salivary secretions. In acute overdosage, the main clinical problem is central nervous system (CNS) depression. In Aus...

Descripción completa

Detalles Bibliográficos
Autores principales: Corallo, Carmela E, Whitfield, Ann, Wu, Adeline
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2747390/
https://www.ncbi.nlm.nih.gov/pubmed/19774213
_version_ 1782172083169525760
author Corallo, Carmela E
Whitfield, Ann
Wu, Adeline
author_facet Corallo, Carmela E
Whitfield, Ann
Wu, Adeline
author_sort Corallo, Carmela E
collection PubMed
description Scopolamine hydrobromide (hyoscine) is an antimuscarinic drug which is primarily used in the prophylaxis and treatment of motion sickness and as a premedication to dry bronchial and salivary secretions. In acute overdosage, the main clinical problem is central nervous system (CNS) depression. In Australia, tablets containing scopolamine hydrobromide 0.3 mg are available over the counter in packs of ten. The recommended dose for adults is one to two tablets as a single dose, repeated four to six hours later, if required. The maximum dose stated on the pack is four tablets over a 24-hour period with a caution regarding drowsiness and blurred vision. We describe a patient who presented with symptoms of anticholinergic syndrome secondary to an unintentional overdose of scopolamine. Whilst at work, the patient noticed that he had forgotten his prescribed medication, domperidone, at home; a friend gave him some travel sickness medication which contained scopolamine for relief of nausea. On a previous occasion, he had experienced a similar, less severe reaction with another anticholinergic agent, loperamide. This report highlights the need to consider nonprescription products, ie, over the counter medications, herbal/nutritional supplements as causes of anticholinergic syndrome when a patient presents with symptoms suggestive of this diagnosis.
format Text
id pubmed-2747390
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-27473902009-09-22 Anticholinergic syndrome following an unintentional overdose of scopolamine Corallo, Carmela E Whitfield, Ann Wu, Adeline Ther Clin Risk Manag Case Report Scopolamine hydrobromide (hyoscine) is an antimuscarinic drug which is primarily used in the prophylaxis and treatment of motion sickness and as a premedication to dry bronchial and salivary secretions. In acute overdosage, the main clinical problem is central nervous system (CNS) depression. In Australia, tablets containing scopolamine hydrobromide 0.3 mg are available over the counter in packs of ten. The recommended dose for adults is one to two tablets as a single dose, repeated four to six hours later, if required. The maximum dose stated on the pack is four tablets over a 24-hour period with a caution regarding drowsiness and blurred vision. We describe a patient who presented with symptoms of anticholinergic syndrome secondary to an unintentional overdose of scopolamine. Whilst at work, the patient noticed that he had forgotten his prescribed medication, domperidone, at home; a friend gave him some travel sickness medication which contained scopolamine for relief of nausea. On a previous occasion, he had experienced a similar, less severe reaction with another anticholinergic agent, loperamide. This report highlights the need to consider nonprescription products, ie, over the counter medications, herbal/nutritional supplements as causes of anticholinergic syndrome when a patient presents with symptoms suggestive of this diagnosis. Dove Medical Press 2009 2009-09-15 /pmc/articles/PMC2747390/ /pubmed/19774213 Text en © 2009 Corallo et al, publisher and licensee Dove Medical Press Ltd This is an Open Access article which permits unrestricted noncommercial use, provided the original work is properly cited.
spellingShingle Case Report
Corallo, Carmela E
Whitfield, Ann
Wu, Adeline
Anticholinergic syndrome following an unintentional overdose of scopolamine
title Anticholinergic syndrome following an unintentional overdose of scopolamine
title_full Anticholinergic syndrome following an unintentional overdose of scopolamine
title_fullStr Anticholinergic syndrome following an unintentional overdose of scopolamine
title_full_unstemmed Anticholinergic syndrome following an unintentional overdose of scopolamine
title_short Anticholinergic syndrome following an unintentional overdose of scopolamine
title_sort anticholinergic syndrome following an unintentional overdose of scopolamine
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2747390/
https://www.ncbi.nlm.nih.gov/pubmed/19774213
work_keys_str_mv AT corallocarmelae anticholinergicsyndromefollowinganunintentionaloverdoseofscopolamine
AT whitfieldann anticholinergicsyndromefollowinganunintentionaloverdoseofscopolamine
AT wuadeline anticholinergicsyndromefollowinganunintentionaloverdoseofscopolamine